ArticleJournal of experimental & clinical cancer research : CR2011

Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer.

Andrea Camerini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.